Standing out from the crowd: How to identify plasma cells
B Cell Overview | Thermo Fisher Scientific - US
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases | SpringerLink
CD antigens expression in B cells | Sino Biological
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
CD antigens expression in B cells | Sino Biological
A Guide to Breg Markers | Biocompare: The Buyer's Guide for Life Scientists
Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
JCI - Genes required for B cell development
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
B Cell Overview | Thermo Fisher Scientific - US
Cells | Free Full-Text | Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre Expression
Antigen-experienced CXCR5- CD19low B cells are plasmablast precursors expanded in SLE | medRxiv
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Molecular analysis of a CD19-negative diffuse large B-cell lymphoma | Haematologica
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
